CHIT1 and neurodegenerative disease: In ALS patients, the CHIT1 levels in CSF significantly elevated compared to controls with healthy control (HC), and CHIT1 levels elevated in the CSF of ALS patients compared to other neurodegenerative diseases (ONDS) control and exhibited an even more substantial increase when compared to ALS-mimicking diseases (AMDS).